Skip to Content

M P4 (Paroxetine Hydrochloride Extended-Release 25 mg)

Pill with imprint M P4 is Purple, Round and has been identified as Paroxetine Hydrochloride Extended-Release 25 mg. It is supplied by Mylan Pharmaceuticals Inc..

Paroxetine is used in the treatment of anxiety and stress; anxiety; depression; generalized anxiety disorder; hot flashes and belongs to the drug class selective serotonin reuptake inhibitors. Excluding Brisdelle: There is positive evidence of human fetal risk during pregnancy. Brisdelle: Not for use in pregnancy. Paroxetine 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M P4

Paroxetine hydrochloride extended-release 25 mg M P4
Paroxetine hydrochloride extended-release 25 mg M P4  Front
Paroxetine hydrochloride extended-release 25 mg M P4  Back
Paroxetine hydrochloride extended-release 25 mg M P4  Front
Paroxetine hydrochloride extended-release 25 mg M P4  Back
Paroxetine hydrochloride extended-release 25 mg M P4
Paroxetine hydrochloride extended-release 25 mg M P4

Paroxetine Hydrochloride Extended-Release

Imprint
M P4
Strength
25 mg
Color
Purple
Size
8.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Selective serotonin reuptake inhibitors
Pregnancy Category
D - Positive evidence of risk - excluding Brisdelle, X - Not for use in pregnancy - Brisdelle
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
ferrosoferric oxide, silicon dioxide, D&C Red No. 30, FD&C Blue No. 2, FD&C Yellow No. 6, lactose monohydrate, magnesium stearate, methacrylic acid - ethyl acrylate copolymer (1:1) type a, microcrystalline cellulose, polydextrose, polysorbate 80, propylene glycol, sodium hydroxide, magnesium silicate, titanium dioxide, triacetin, triethyl citrate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00378-2004 Mylan Pharmaceuticals Inc.
51079-0825 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Related Images for "M P4"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.